Bristol-Myers Squibb Company

About Bristol-Myers Squibb Company

Bristol-Myers Squibb is a global biopharmaceutical company headquartered in New York City. It discovers, develops, manufactures and markets medicines for cancer, cardiovascular, immunologic, fibrotic and infectious diseases. Formed through the 1989 merger of Bristol-Myers and Squibb, the company has pioneered therapies such as Opdivo, Yervoy and Eliquis. Operating in more than 60 countries, it invests heavily in R&D and partnerships to advance precision oncology, cell therapy and immunotherapy. BMS acquired Celgene in 2019, expanding its oncology and hematology portfolio. The company is committed to sustainability, access to medicines and global health equity initiatives.